<DOC>
	<DOCNO>NCT00337675</DOCNO>
	<brief_summary>This year-long study evaluate efficacy daily intermittent treatment asthma child experience symptom episodically ( i.e. , seasonally , usually context upper respiratory tract infection ) .</brief_summary>
	<brief_title>Intermittent Daily Dosing Episodic ( Periodic ) Asthma ( 0476-302 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patients age 6 month 5 year episodic ( periodic ) asthma Patients otherwise good health Patients persistent asthma ( continual asthma symptom )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>